Symposium Overview
As part of the 20th Meeting of the European Association for Haematopathology virtual event, Thermo Fisher Scientific hosted an educational industry symposium focused on the uses of next-generation sequencing (NGS) in lymphoid research.
Next-generation sequencing (NGS) is increasingly being adopted for BCR and TCR sequence analysis, as well as targeted gene panels in lymphoma research. NGS has advantages over other more traditional approaches as it provides low limits of detection (LOD), and a greater flexibility to multiplex.
In this on-demand presentation, lab directors share their insights and experience on the value of NGS in their research.
